IL13 and idiopathic pulmonary fibrosis: Although investigational drugs targeting some cytokines such as IFN-γ, TNF-α, and IL-13 have not shown satisfactory efficacy, the development of anti-IPF drugs targeting cytokine and growth factor pathways is still promising.